Endogenex
Developer of a medical device system designed to improve metabolic function in individuals with diabetes by resetting metabolic signalling in the small intestine. The company's device delivers control...
Valuation
$168M
Market implied
Share Price
N/A
Total Raised
$140.4M
Last Round
N/A